About Robert O'Holla
Form D filings for Nuvaira from 2021 to 2022 list Robert O'Holla as director.
Form D filings also name Robert O'Holla as a director at Gynesonics.
Robert O'Holla first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Robert O'Holla in the role, so the role may have started earlier or lasted longer.
Nuvaira, Inc.
Director
2021 – 2022 · Minneapolis, MN
Develops a lung treatment device for people with chronic obstructive pulmonary disease.
Key Colleagues at Startups
The people Robert O'Holla works with at each company, as listed on that company's latest Form D.
Nuvaira, Inc. · Form D/A, Jan 19, 2022
JR
Jonathan Root
Director
YL
Yoh-Chie Lu
Director
GR
Gary Rieschel
Director
Dennis Wahr
President & CEO, director
TH
Tim Herbert
Director
HP
Henry Plain
Director
MC
Michael Carusi
Director
Gynesonics, Inc. · Form D, Dec 29, 2021
SS
Susan Stimson
Director
CO
Christopher Owens
Executive officer and director
DN
David Neustaedter
Director
CL
Chandra Leo
Director
DP
David Pacitti
Director
RB
Robert Brown
Chief Financial Officer
JS
Jeffrey Schwartz
Director
JB
Jordan Bajor
Executive officer
KT
Karen Talmadge
Director
JE
Joyce Erony
Director
MC
Mike Carusi
Director